Lv3
250 积分 2024-12-03 加入
Mass spectrometric characterization of the hypoxia‐inducible factor (HIF) stabilizer drug candidate BAY 85‐3934 (molidustat) and its glucuronidated metabolite BAY‐348, and their implementation into routine doping controls
1个月前
已关闭
Development of stabilized fuzapladib solution for injection: forced degradation study and pharmacokinetic evaluation
7个月前
已完结
皖公网安备34019202002308
